American Bio Medica Corporation
$0.00$0.00 (0.0%)
American Bio Medica Corporation’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
OTC · DMTKQ · USD
Stock price, earnings
Quote as of Aug 12, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
DermTech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow DermTech, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
DermTech, Inc. operates as a molecular diagnostics firm specializing in developing and commercializing innovative, non-invasive genomic tests designed to assist in the early detection and ongoing management of melanoma within the United States. Its flagship product, the DermTech Melanoma Test (DMT), offers a non-surgical method for improved melanoma detection, with further development underway for non-melanoma skin cancers. Complementing this, the DermTech Smart Sticker facilitates the non-invasive collection of skin samples, presenting a gentler alternative to traditional scalpel biopsies for suspicious lesions. Additionally, the company extends its expertise to pharmaceutical firms, offering contract research services and its proprietary technology platform for use in clinical trials. DermTech also creates gene expression assays targeting conditions like psoriasis, atopic dermatitis, and skin aging, aiding pharmaceutical partners in dermatological drug development and offering bespoke gene assay solutions. Its products are distributed primarily through pathology and oncology specialists. Headquartered in San Diego, California, DermTech, Inc. and an affiliated entity initiated voluntary Chapter 11 bankruptcy proceedings for reorganization in the U.S. Bankruptcy Court for the District of Delaware on June 18, 2024.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2022 | Mar 2, 2023 | -$0.93+3.43% vs estimate | $2.99M+17.26% vs estimate |
|---|
| Q3 2022 | Nov 3, 2022 | -$0.96+3.03% vs estimate | $3.57M-23.35% vs estimate |
|---|
THE ANALYST VIEW
3 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
American Bio Medica Corporation’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00-$0.04 (-99.75%)
American CryoStem Corporation: Healthcare · Biotechnology.
$0.00+$0.00 (+1,000.0%)
Allied Healthcare Products, Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
ER Urgent Care Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.39% below the high.
$0.00+$0.00 (0.0%)
GeneThera, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.33% below the high.
$0.00$0.00 (0.0%)
Lescarden Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Tauriga Sciences, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
MEDirect Latino, Inc.: Healthcare · Medical - Distribution.